Form Bio showcases AI-based AAV gene therapy design at ASGCT 27th Annual Meeting in Baltimore.
Computational life sciences solutions provider, Form Bio, participates in the ASGCT 27th Annual Meeting in Baltimore, showcasing AI-based AAV gene therapy design and development. Multiple presentations, including oral sessions and workshops, aim to expedite market delivery and enhance success rates of gene and cell therapies. Solutions accelerate timelines, reduce costs, and improve safety and yields.
May 03, 2024
3 Articles